TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -26.79%339.68M | ---- | -32.97%748.86M | ---- | -14.32%464M | ---- | 99.75%1.12B | ---- | 155.82%541.56M |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | 173.64%951.69K | ---- | -368.06%-4.49M | ---- | ---1.29M | ---- | -38.30%1.67M | ---- | ---- |
Impairment and provisions: | ---- | -72.56%17.97M | ---- | -17.99%133.52M | ---- | 38.20%65.49M | ---- | 145.96%162.8M | ---- | 172.33%47.39M |
-Other impairments and provisions | ---- | 11.81%15.03M | ---- | ---- | ---- | --13.44M | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -112.68%-209.36K | ---- | 174.95%1.4M | ---- | 258.85%1.65M | ---- | -96.86%-1.87M | ---- | ---1.04M |
Asset sale loss (gain): | ---- | -150.68%-925.63K | ---- | 7.00%-1.24M | ---- | -8,117.86%-369.25K | ---- | -156.10%-1.33M | ---- | 102.60%4.61K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -150.68%-925.63K | ---- | 7.00%-1.24M | ---- | -8,117.86%-369.25K | ---- | -156.10%-1.33M | ---- | 102.60%4.61K |
Depreciation and amortization: | ---- | 33.21%153.87M | ---- | 34.35%259.86M | ---- | 22.66%115.51M | ---- | -13.28%193.42M | ---- | -9.90%94.17M |
-Amortization of intangible assets | ---- | 23.92%44.58M | ---- | 78.74%92.34M | ---- | 41.66%35.97M | ---- | -49.67%51.66M | ---- | -48.72%25.39M |
-Other depreciation and amortization | ---- | -0.81%8.36M | ---- | 12.62%16.64M | ---- | 19.27%8.43M | ---- | 50.18%14.78M | ---- | 58.47%7.07M |
Financial expense | ---- | 511.51%25.79M | ---- | 280.81%22.6M | ---- | -1,377.15%-6.27M | ---- | -541.95%-12.5M | ---- | -67.17%490.77K |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 97.21%-39.25M | ---- | -166.24%-1.81B | ---- | -577.88%-1.4B | ---- | -96.34%-681.59M | ---- | -53.01%-207.16M |
Accounts receivable (increase)decrease | ---- | 12.66%-410.37M | ---- | 67.49%-239.2M | ---- | 5.02%-469.85M | ---- | -325.86%-735.8M | ---- | -513.73%-494.7M |
Accounts payable increase (decrease) | ---- | -87.46%10.78M | ---- | -55.43%65.8M | ---- | -68.76%85.97M | ---- | -41.84%147.65M | ---- | 135.81%275.14M |
Special items of business | ---- | -51.16%28.82M | ---- | -9.27%119.36M | ---- | -19.43%59.02M | ---- | 741.09%131.56M | ---- | 65,299.59%73.25M |
Adjustment items of business operations | 110.46%115.36M | 108.55%98.31M | 102.02%10.58M | -536.17%-827.53M | -514.03%-1.1B | -549.25%-1.15B | -394.91%-524.98M | -67.65%189.73M | -29.77%266.31M | 8.59%255.86M |
Net cash from operations | 110.46%115.36M | 111.66%127.13M | 102.02%10.58M | -320.42%-708.17M | -514.03%-1.1B | -431.33%-1.09B | -394.91%-524.98M | -46.65%321.29M | -29.77%266.31M | 39.61%329.11M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | -94.47%233.01K | -86.31%506.81K | -18.48%739.86K | -49.14%3.28M | 202.50%4.21M | 255.94%3.7M | 332.19%907.59K | 129.46%6.45M | --1.39M | --1.04M |
Sale of fixed assets | 726.40%2.13M | -74.74%62.47K | -99.66%1.47K | -6.36%2.37M | 2,686.09%257.8K | 4,022.50%247.35K | --433.47K | 282.54%2.53M | -95.87%9.25K | -97.31%6K |
Purchase of fixed assets | 50.73%-241.66M | 45.09%-195.57M | 47.67%-132.65M | -8.74%-850.93M | -7.49%-490.45M | -3.11%-356.17M | 1.92%-253.47M | -38.62%-782.53M | -2.07%-456.29M | -6.24%-345.44M |
Recovery of cash from investments | 23.00%761.34M | 565.87%279.59M | -27.72%160.15M | -31.34%787M | 61.71%618.96M | -77.98%41.99M | 21.60%221.55M | 123.01%1.15B | --382.77M | --190.68M |
Cash on investment | -100.04%-1.03B | ---410M | 0.58%-265M | -31.97%-677M | -281.41%-514.9M | ---- | ---266.56M | 54.92%-513M | 32.28%-135M | ---- |
Other items in the investment business | -48.60%1.65M | -71.91%792.46K | -92.37%213.16K | -52.55%3.69M | -49.44%3.2M | -55.06%2.82M | 1,514.99%2.79M | 249.17%7.77M | 59.38%6.34M | 166.88%6.28M |
Net cash from investment operations | -33.69%-506.31M | -5.60%-324.62M | 19.63%-236.55M | -452.09%-731.6M | -88.63%-378.72M | -108.50%-307.41M | -288.02%-294.34M | 88.80%-132.51M | 68.73%-200.78M | 57.69%-147.44M |
Net cash before financing | 73.61%-390.95M | 85.87%-197.49M | 72.42%-225.97M | -862.70%-1.44B | -2,360.56%-1.48B | -869.45%-1.4B | -902.04%-819.33M | 132.51%188.77M | 124.92%65.53M | 261.14%181.67M |
Cash flow from financing activities | ||||||||||
New borrowing | -17.02%1.06B | -25.12%798.09M | 34.84%445.72M | 2,037.33%1.68B | --1.28B | --1.07B | 1,329.51%330.56M | -53.02%78.57M | ---- | ---- |
Refund | -2,217.91%-823.76M | -1,932.03%-722.16M | ---450.77M | -243.79%-253.27M | 52.44%-35.54M | 52.44%-35.54M | ---- | 37.22%-73.67M | ---74.73M | ---74.73M |
Dividends paid - financing | 3.03%-121.88M | -1,242.48%-84.6M | -1,502.93%-12.41M | -148.36%-136.93M | -137.55%-125.7M | -1,047.14%-6.3M | -71.93%-774.08K | -2,416.35%-55.13M | -3,975.45%-52.91M | -106.27%-549.36K |
Absorb investment income | --14.54M | --14.54M | ---- | -92.57%42.79M | ---- | ---- | ---- | -17.36%575.81M | -21.04%537.17M | ---- |
Other items of the financing business | 8.33%-15.73M | -47.47%-13.4M | -4.14%-6.83M | -2.91%-21.61M | -12.95%-17.16M | -27.91%-9.08M | -26.23%-6.56M | 18.34%-20.99M | -20.94%-15.19M | 1.27%-7.1M |
Net cash from financing operations | -89.86%111.25M | -100.74%-7.53M | -107.51%-24.29M | 159.67%1.31B | 178.12%1.1B | 1,331.89%1.01B | 1,749.31%323.23M | -29.80%504.59M | -48.20%394.34M | -293.94%-82.38M |
Effect of rate | -11.45%-9.47M | -275.74%-5.59M | -9.21%-2.1M | -80.93%2.13M | -23,010.57%-8.5M | 43.19%-1.49M | -170.93%-1.93M | 711.48%11.17M | 96.06%-36.77K | -112.98%-2.62M |
Other items affecting net cash | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net Cash | 27.27%-279.7M | 46.47%-205.02M | 49.55%-250.26M | -118.68%-129.49M | -183.63%-384.56M | -485.75%-383M | -514.68%-496.1M | 401.66%693.36M | -7.72%459.87M | 241.31%99.29M |
Begining period cash | -11.37%992.92M | -11.37%992.92M | -11.37%992.92M | 169.46%1.12B | 169.46%1.12B | 169.46%1.12B | 169.46%1.12B | 48.82%415.76M | 48.82%415.76M | 48.82%415.76M |
Cash at the end | -3.23%703.76M | 6.32%782.32M | 19.01%740.56M | -11.37%992.92M | -16.94%727.22M | 43.59%735.8M | 16.38%622.26M | 169.46%1.12B | 12.72%875.58M | 146.50%512.43M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.